Outcomes of Patients With Hypertrophic Obstructive Cardiomyopathy and Pacemaker Implanted After Alcohol Septal Ablation-Reference-Cited by-同舟云学术

Outcomes of Patients With Hypertrophic Obstructive Cardiomyopathy and Pacemaker Implanted After Alcohol Septal Ablation

Published:2022-10 Issue:19 Volume:15 Page:1910-1917
ISSN:1936-8798
Container-title:JACC: Cardiovascular Interventions
language:en
Short-container-title:JACC: Cardiovascular Interventions

Author:

Veselka Josef,Liebregts Max,Cooper Robert,Faber Lothar,Januska Jaroslav,Kashtanov Maksim^ORCID,Tesarkova Klara Hulikova,Hansen Peter Riis,Seggewiss Hubert^ORCID,Shloydo Eugene,Popov Kirill,Hansvenclova Eva,Bonaventura Jiri,Berg Jurriën ten,Stables Rodney Hilton,Polakova Eva

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference18 articles.

1. Management of hypertrophic cardiomyopathy;Maron;J Am Coll Cardiol,2022

2. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy;Elliott;Eur Heart J,2014

3. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guideline;Ommen;J Am Coll Cardiol,2020

4. Transcatheter septal ablation in hypertrophic obstructive cardiomyopathy: a technical guide and review of published results;Rigopoulos;Heart Fail Rev,2018

5. Alcohol septal ablation versus surgical septal myectomy: comparison of effects on atrioventricular conduction tissue;Talreja;J Am Coll Cardiol,2004

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Distal Ventricular Pacing for Drug-Refractory Mid-Cavity Obstructive Hypertrophic Cardiomyopathy: A Randomized, Placebo-Controlled Trial of Personalized Pacing;Circulation: Arrhythmia and Electrophysiology;2024-07

2. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: do mitral valve leaflet length, septal thickness, or sex affect the outcome?;Cardiovascular Intervention and Therapeutics;2024-05-28

3. Invasive Management of Hypertrophic Cardiomyopathy With Clinically Important Obstruction: Surgical Myectomy Is Superior, but Only When Accessible;CAN J CARDIOL;2024

4. Myosin Inhibitors for Hypertrophic Obstructive Cardiomyopathy (HOCM): Is HOCM Passing Another Crossroads?;Canadian Journal of Cardiology;2024-05

5. Percutaneous intramyocardial septal radiofrequency ablation after 5-year follow-up;Heart;2024-02-22